FDA Drug Application (022321) for EMBEDA by ALPHARMA PHARMS

Back to FDA Applications sponsored by ALPHARMA PHARMS

Application Number022321
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage20MG;0.8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMBEDA
Active IngredientMORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient MORPHINE SULFATE11
List of drugs with Active Ingredient NALTREXONE HYDROCHLORIDE5


Back to FDA Applications sponsored by ALPHARMA PHARMS